Maya Gambarin-Gelwan, MD

My areas of interest include a wide spectrum of liver disease, including treatment of viral hepatitis B and C, immune-mediated liver diseases, and metabolic liver diseases. I have a strong interest in management of chronic and advanced liver disease in patients with an underlying malignancy and in liver-related complications of cancer therapies. Alongside my primary interest in hepatology, I am a strong believer in cancer prevention and early detection, and screening colonoscopy is an integral part of my practice.

Prior to joining the Gastroenterology and Nutrition Service at Memorial Sloan-Kettering, I was on the faculty at Weill Cornell Medical College where I was involved as both principal and co-investigator in multiple clinical trials investigating novel agents for the treatment of chronic hepatitis C and B. My other academic interests include the detection and diagnosis of hepatocellular carcinoma, nonalcoholic fatty liver, vaccination patterns in patients with chronic liver disease, predictors of response to IFN-based therapy in chronic hepatitis C patients and outcomes of antiviral therapy for chronic hepatitis C in cancer survivors, effects of prior resolved or occult hepatitis B infection on the risk of hepatocellular carcinoma, and disease progression in patients with chronic hepatitis C.

I perform standard upper endoscopy, colonoscopy, and percutaneous liver biopsy in Memorial  Sloan-Kettering's GI endoscopy unit and see outpatients needing advice on the management of liver diseases in the outpatient facility at the main campus.